Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,630 active trials11 approved drugs139 evidence items
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,171 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00069160 | Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Oct 12, 2012 | clinicaltrials |
| NCT01012336 | Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin | completed | Phase 2 | 89 | Samsung Medical CenterOTHER | 1 | Oct 10, 2012 |
| clinicaltrials |
| NCT00433407 | T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | completed | N/A | 12 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00563836 | Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer | completed | Phase 2 | 41 | Neovii BiotechINDUSTRY | 2 | Oct 3, 2012 | clinicaltrials |
| NCT00002459 | Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus | completed | Phase 3 | 224 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Sep 24, 2012 | clinicaltrials |
| NCT00003939 | Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | completed | Phase 2 | 132 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Sep 24, 2012 | clinicaltrials |
| NCT00006230 | Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer | completed | Phase 2 | 51 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00006357 | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | 91 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00014599 | Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva | completed | Phase 2 | 31 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00022620 | Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer | completed | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00052312 | Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer | completed | Phase 2 | 141 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT01566669 | Efficacy and Safety of Parecoxib on Morphine Patient-controlled Epidural Analgesia (PCEA) After Gynecologic Surgery(PCEA) | completed | N/A | 294 | Liu WeifengOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00003072 | Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer | completed | Phase 2 | 80 | University of California, San FranciscoOTHER | 1 | Sep 21, 2012 | clinicaltrials |
| NCT00316706 | Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine | completed | Phase 3 | 1,245 | GlaxoSmithKlineINDUSTRY | 5 | Sep 18, 2012 | clinicaltrials |
| NCT00392769 | Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer | completed | Phase 2 | 33 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 6, 2012 | clinicaltrials |
| NCT01041235 | Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies | completed | Phase 1 | 29 | Azaya Therapeutics, Inc.INDUSTRY | 1 | Sep 6, 2012 | clinicaltrials |
| NCT01029990 | Randomized Controlled Trial to Study Interventions to Increase Participation in Cervical Cancer Screening Program | completed | Early Phase 1 | 8,800 | Göteborg UniversityOTHER | 0 | Aug 30, 2012 | clinicaltrials |
| NCT00003772 | Quality-of-Life Assessment in Patients With Ovarian Cancer | completed | — | 372 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Aug 27, 2012 | clinicaltrials |
| NCT01328028 | Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New Zealand | completed | — | 244 | GlaxoSmithKlineINDUSTRY | 0 | Aug 27, 2012 | clinicaltrials |
| NCT00296816 | TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary(TEACO) | completed | Phase 2 | 132 | SanofiINDUSTRY | 1 | Aug 23, 2012 | clinicaltrials |
| NCT00452985 | Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer(OCSTUD) | completed | — | 30 | SanofiINDUSTRY | 1 | Aug 14, 2012 | clinicaltrials |
| NCT00004081 | Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer | completed | Phase 2 | 30 | Beth Israel Deaconess Medical CenterOTHER | 1 | Aug 13, 2012 | clinicaltrials |
| NCT00165152 | Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing | completed | N/A | 150 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00501644 | Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer | completed | Phase 2 | 59 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00059618 | PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer | completed | Phase 1 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00084903 | Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears | completed | N/A | 1,070 | M.D. Anderson Cancer CenterOTHER | 2 | Aug 2, 2012 | clinicaltrials |
| NCT00386217 | Psychosocial Impact of Cancer-Related Female Infertility | completed | — | 239 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00486707 | Ovarian Cancer Patient Questionnaire on Genetic Testing | completed | — | 237 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00505726 | Reflectance Confocal Imaging in Cervical Cancer Patients | completed | — | 39 | M.D. Anderson Cancer CenterOTHER | 2 | Aug 1, 2012 | clinicaltrials |
| NCT00511615 | Molecular Imaging for Detection of Cervical Intraepithelial Neoplasia | completed | — | 30 | M.D. Anderson Cancer CenterOTHER | 2 | Aug 1, 2012 | clinicaltrials |
| NCT00513123 | Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia | completed | — | 100 | M.D. Anderson Cancer CenterOTHER | 3 | Aug 1, 2012 | clinicaltrials |
| NCT00528034 | Lymphoscintigraphy in Patients With Vaginal Cancer | completed | N/A | 14 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT01045187 | Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer | completed | N/A | 15 | Xoft, Inc.INDUSTRY | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00334295 | Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma. | completed | Phase 2 | 35 | AstraZenecaINDUSTRY | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00505739 | Mifepristone for Patients With Endometrial Cancer and LGESS | completed | Phase 2 | 13 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00377429 | Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy | completed | Phase 2 | 47 | Neovii BiotechINDUSTRY | 1 | Jul 19, 2012 | clinicaltrials |
| NCT00750672 | Follow-up Care After Treatment for Endometrial Cancer | completed | — | 20 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT00002764 | Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | completed | Phase 3 | 340 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00003209 | Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer | completed | Phase 3 | 700 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00003267 | Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer | completed | Phase 3 | 214 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Jul 11, 2012 | clinicaltrials |
| NCT00267488 | Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer | completed | Phase 2 | 70 | GlaxoSmithKlineINDUSTRY | 3 | Jul 11, 2012 | clinicaltrials |
| NCT00628901 | A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) | completed | Phase 4 | 60 | Boston Scientific CorporationINDUSTRY | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00002903 | Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer | completed | Phase 2 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00002916 | Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer | completed | Phase 2 | 44 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 2, 2012 | clinicaltrials |
| NCT00281515 | Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer | completed | Phase 2 | 105 | AGO Study GroupOTHER | 1 | Jun 29, 2012 | clinicaltrials |
| NCT00003127 | S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer | completed | Phase 2 | 57 | SWOG Cancer Research NetworkNETWORK | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00003369 | S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer | completed | Phase 2 | 56 | SWOG Cancer Research NetworkNETWORK | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00877253 | Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer | completed | Phase 1 | 18 | Samyang Biopharmaceuticals CorporationINDUSTRY | 0 | Jun 12, 2012 | clinicaltrials |
| NCT00773071 | Added-value of SPECT/CT in Patients Undergoing LM/SL for Gynecological Cancers | completed | N/A | 15 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00003669 | Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jun 7, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Oct 12, 2012source: clinicaltrials